Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The calcyphosine-like pseudogene (ENSG00000248349) is classified as a pseudogene—a genomic sequence resembling a functional gene that has lost its protein-coding potential due to mutations or other genomic changes[5]. Pseudogenes may share sequence homology with their ancestral (parental) genes but are typically not translated into functional proteins. While some pseudogenes can be transcribed and even play regulatory roles (e.g., as potential competing endogenous RNAs, miRNA decoys, or producers of noncoding RNAs), there is no known therapeutic, diagnostic, or direct biological function attributed to ENSG00000248349 specifically[1][7]. Pseudogenes, by definition, are not considered therapeutic targets as they lack protein-coding function and generally have no established roles in disease pathways or druggability[5][1]. If you intended to refer to a functionally relevant calcyphosine-like protein, consider instead CAPSL (calcyphosine-like protein, ENSG00000152611), which is a calcium-binding protein but distinct from this pseudogene[6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Calcyphosine-like pseudogene.